Together, these highlight a pivotal role for mammary fibroblasts located in the tumor cell microenvironment in determining the phenotypic properties of ER+ breast cancer cells and their sensitivity or resistance to endocrine therapy. This evidence concerns the gene ESR1 and neoplasm.